Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,581.3
-14.7 (-0.56%)

 

  • STI Straits Times Index
    2,581.3
    -14.7 (-0.56%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,564.6
    -11.8 (-0.75%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,183.0
    -47.7 (-0.19%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,360.1
    39.4 (1.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,289.4
    39.8 (0.17%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,247.7
    8.4 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,818.9M
  • Value: 1,195.1M
  • Rise: 145
  • Fall: 205
  • Unch: 458

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.036-
Yinda Infocomm0.035-
Rex Intl0.168-0.013
ChinaKundaTech0.028+0.002
FJ Benjamin^0.020+0.002
Singapore-eDev0.062-0.012
Medtecs Intl1.610+0.050
ThaiBev0.605-
Kitchen Culture0.215-0.105
AnAn Intl0.037-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

CEL-SCI CORP CEL-SCI CORPORATION
Updated on 13 Aug 2020 (End of trading day)
Last (USD): 13.050 Change: +0.610 High: 13.230 Remarks: -
Change (%): +4.90 Low: 12.510
Open 12.630 Yesterday's Close 12.440000000000001
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 425,405 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.37089 Trailing EPS (USD) e -3.16810 NAV (USD) b 2.0367
PE a - Trailing PE f - Price / NAV b 6.4074
Dividend (USD) d - Cash In Hand (USD) g 2.1569 Issued & Paid-up Shares c 38,624,100
Dividend Yield (%) d - Price / Cash In Hand g 6.050 Treasury Shares h -
Market Cap (M) 121.835 Enterprise Value (M) 115.856
Piotroski F Score 2 Exchange Code CVM Par Value ( $ ) n.a.
52 Weeks Volatility (%) 98.43 Free Float (%) 95.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 12 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CEL-SCI CORP NYSE American 121.835 - - 6.4074 -
Industry Biotechnology NYSE American 138.445 - - 4.0030 -
Local Peer NANOVIRICIDES INC NYSE American 359.510 - - 25.1101 -
Local Peer CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL NYSE American 303.788 - - 60.0000 -
Local Peer PFENEX INC NYSE American 301.171 284.634 - 4.0758 -
Local Peer IBIO INC NYSE American 246.899 - - 62.2951 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 137.983 - - 1.3876 -
Local Peer AIM IMMUNOTECH INC NYSE American 100.815 - - 2.9357 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 81.657 2.283 2.201 0.9420 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 77.983 - - 1.1325 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 77.653 - - 2.9263 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 71.485 - - -9.6436 -
Local Peer 22ND CENTURY GROUP INC NYSE American 69.877 - - 1.2972 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 62.273 - - 1.8599 -
Other Local Peers ORAGENICS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 140,835.979 17.959 19.295 13.2129 2.436
Global Peer CSL ASX 126,834.048 47.275 43.784 14.6656 0.950
Global Peer GILEAD SCIENCES INC NASDAQ 85,478.630 15.871 - 4.7417 3.732
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer VERTEX PHARMACEUTICAL NASDAQ 69,583.759 59.129 33.441 9.2541 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 64,993.791 30.718 21.784 7.1758 -
Global Peer ILLUMINA INC NASDAQ 51,615.380 51.512 74.481 11.3117 -
Global Peer BIOGEN INC NASDAQ 45,679.633 7.757 7.707 4.0393 -
Global Peer WUXI BIO HKEx 216,907.105 188.686 188.685 15.1677 -
Global Peer SEATTLE GENETICS INC NASDAQ 27,863.880 - - 15.3598 -
Other Global Peers MODERNA INC (NASDAQ), ALEXION PHARMACEUTICAL INC (NASDAQ), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), EXELIXIS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), FIBROGEN INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GENSCRIPT BIO (HKEx), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), FATE THERAPEUTICS (NASDAQ), ALKERMES PLC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INSMED INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), ALLOVIR INC (NASDAQ), VAXCYTE INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), VERACYTE INC (NASDAQ), ALPHAMAB-B (HKEx), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), AKEBIA THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), NANOSTRING TECHNOLOGIES INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), COMPUGEN (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MESOBLAST LTD (ASX), COHERUS BIOSCIENCES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CORTEXYME INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), ARVINAS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ASCENTAGE-B (HKEx), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), NANTKWEST INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), FRONTAGE (HKEx), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PERSONALIS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), KINTOR PHARMA-B (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PRECIGEN INC (NASDAQ), KADMON HLDGS INC (NYSE), AKOUOS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), AGENUS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ARDELYX INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DPHARMA (Bursa), XBIOTECH INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ATHERSYS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), CLOVIS ONCOLOGY INC (NASDAQ), ASCLETIS-B (HKEx), RIGEL PHARMACEUTICALS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), IVERIC BIO INC (NASDAQ), KAMADA (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MERUS B V (NASDAQ), ESSEX BIO-TECH (HKEx), MANNKIND CORPORATION (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), TREVENA INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), IMV INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AFFIMED N V (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHIASMA INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), VERASTEM INC (NASDAQ), NEXTCURE INC (NASDAQ), MEDICINOVA INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), TELIX PHARMACEUTIC (ASX), CASI PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), XOMA CORP (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), FIVE PRIME THERAPEUTICS (NASDAQ), IMUGENE LIMITED (ASX), VTV THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), CONTRAFECT CORP (NASDAQ), INMUNE BIO INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SESEN BIO INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), CHAMPIONS ONCOLOGY INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), BIONANO GENOMICS INC (NASDAQ), SAVARA INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ARAVIVE INC (NASDAQ), VACCINEX INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), RESTORBIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), MEMPHASYS LTD (ASX), RECRO PHARMA INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ANTEOTECH LIMITED (ASX), MONOPAR THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), IMMUTEP LTD (ASX), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), BIOTRON (ASX), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), CT ENTERPRISE (HKEx), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), BIONOMICS LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), EVOGENE LTD (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), BIOSINO BIO-TEC (HKEx), AETERNA ZENTARIS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CONSTELLATION TECHNOLOGIES LTD (ASX), BIOCARDIA INC (NASDAQ), REGENEUS LTD (ASX), AZURRX BIOPHARMA INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), Suntar Eco-City (SGX), APTEVO THERAPEUTICS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), REGENT PACIFIC (HKEx), BIO-PATH HOLDINGS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), RHINOMED LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), SENESTECH INC (NASDAQ), CRYOSITE (ASX), HAO WEN HLDGS (HKEx), AURIS MEDICAL HOLDING LTD (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.860
+7.05 %
10 Days -+0.540
+4.32 %
20 Days --1.410
-9.75 %
Medium Term Return 3 Months --2.650
-16.88 %
6 Months --1.170
-8.23 %
1 Year -+4.900
+60.12 %
Long Term Return 2 Years -+11.870
+1005.93 %
3 Years -+10.610
+434.84 %
5 Years --0.325
-2.43 %
Annualised Return Annualised --
-0.49 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.000 - 18.000 Change From 1 Year Low +7.050 % Change From 1 Year Low (%) +117.50
Change From 1 Year High -4.950 % Change From 1 Year High (%) -27.50
2 Years Range 1.000 - 18.000 Change From 2 Years Low +12.050 % Change From 2 Years Low (%) +1205.00
Change From 2 Years High -4.950 % Change From 2 Years High (%) -27.50
5 Years Range 0.817 - 20.000 Change From 5 Years Low +12.233 % Change From 5 Years Low (%) +1498.29
Change From 5 Years High -6.950 % Change From 5 Years High (%) -34.75
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients; and CEL-2000 and CEL-4000 which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Aug 2020 12.630 13.230 12.510 13.050 425,405 -
12 Aug 2020 11.920 12.680 11.550 12.440 524,502 -
11 Aug 2020 12.000 12.310 11.440 11.690 443,935 -
10 Aug 2020 12.270 12.602 12.000 12.030 315,771 -
07 Aug 2020 12.070 12.360 11.860 12.190 248,525 -
06 Aug 2020 12.130 12.440 11.860 12.210 328,080 -
05 Aug 2020 12.250 12.400 11.910 12.270 335,644 -
04 Aug 2020 12.030 12.590 12.000 12.040 307,766 -
03 Aug 2020 12.750 12.750 12.000 12.710 397,398 -
31 Jul 2020 12.600 13.020 12.090 12.510 474,964 -
30 Jul 2020 12.200 12.710 11.825 12.500 480,105 -
29 Jul 2020 12.860 12.960 12.050 12.190 615,550 -
28 Jul 2020 13.330 13.500 12.810 12.840 398,904 -
27 Jul 2020 13.400 13.714 12.910 13.260 540,562 -
24 Jul 2020 13.250 13.980 12.510 13.290 862,438 -
23 Jul 2020 12.900 13.320 12.700 13.020 365,259 -
22 Jul 2020 13.420 13.490 12.610 13.130 605,190 -
21 Jul 2020 13.410 13.650 13.000 13.250 428,701 -
20 Jul 2020 14.040 14.398 13.010 13.400 854,995 -
17 Jul 2020 14.400 14.640 14.030 14.460 485,441 -
16 Jul 2020 13.750 14.490 13.630 14.400 394,828 -
15 Jul 2020 13.850 13.970 13.280 13.830 403,454 -
Summary
Current 2 Weeks
(31 Jul 2020 to 13 Aug 2020)		 12.600 13.230 11.440 13.050 3,801,990 -
Previous 2 Weeks
(17 Jul 2020 to 30 Jul 2020)		 14.400 14.640 11.440 12.500 5,637,145 -
4 Weeks from
(18 Jun 2020 to 16 Jul 2020)		 14.480 14.700 11.440 14.400 18,113,717 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.